Comparison of cefadroxil and cephalexin in the treatment of community-acquired pneumonia.
Thirty-four patients with community-acquired acute pneumonias were treated in a prospective, randomized trial with either cefadroxil, 500 mg twice daily, or cephalexin, 250 mg four times daily. In both groups of patients, the presence of chronic illnesses predisposing to pneumonia was common. Strept...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1983
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185131/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6605713/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.2.163 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|